Aravive Presents Updated Clinical Data at ASCO Showing Continued Best-in-Class…
Abstract selected for oral discussion on Genitourinary Cancer on Saturday, June 4, 2022Development of biomarker offers the potential of a first in class targeted therapy in renal…